IMATINIB MESYLATE (IMATINIB MESYLATE) — FDA Approval ANDA207818 (NATCO PHARMA LTD)
IMATINIB MESYLATE (IMATINIB MESYLATE) — FDA Approval ANDA207818 (NATCO PHARMA LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: IMATINIB MESYLATE; Active ingredients: IMATINIB MESYLATE; Application number: ANDA207818.
| Brand name | IMATINIB MESYLATE |
|---|---|
| Active ingredients | IMATINIB MESYLATE |
| Application number | ANDA207818 |
| Sponsor | NATCO PHARMA LTD |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20190301 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →